Piper Sandler Starts IO Biotech (IOBT) at Overweight, 'Limited Downside From Here'
Tweet Send to a Friend
(Updated - September 28, 2023 4:45 AM EDT)
Piper Sandler analyst Christopher Raymond initiates coverage on IO Biotech (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Christopher Raymond initiates coverage on IO Biotech (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
